American Medical Technologies Inc.
American Medical Technologies Inc. (ADLI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
adli · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
American Medical Technologies Inc.You ADLI | $0M | N/A | — | -$0.11 |
 BG Medicine, Inc. BGMD | $0M | N/A | — | -$0.55 |
 BIMI International Medical Inc. BIMI | $0M | N/A | — | -$8.40 |
 ContraFect Corporation CFRXQ | $0M | N/A | — | -$124.97 |
 DMK Pharmaceuticals Corporation DMKPQ | $0M | N/A | — | -$12.37 |
 Grupo International Inc. GRPI | $0M | N/A | — | -$0.01 |
 IMV Inc. IMVIF | $0M | N/A | — | -$4.37 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for American Medical Technologies Inc. (ADLI) measures how much investors pay for each dollar of the company's trailing earnings. ADLI's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.11.
Frequently asked questions
ADLI pe ratio · 6 questionsADLI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.11. Data sourced from Financial Modeling Prep via ADLI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · American Medical Technologies Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09